Authors
Shinya Goto, Pantep Angchaisuksiri, Jean‐Pierre Bassand, A John Camm, Helena Dominguez, Laura Illingworth, Harry Gibbs, Samuel Z Goldhaber, Shinichi Goto, Zhi‐Cheng Jing, Sylvia Haas, Gloria Kayani, Yukihiro Koretsune, Toon Wei Lim, Seil Oh, Jitendra PS Sawhney, Alexander GG Turpie, Martin van Eickels, Freek WA Verheugt, Ajay K Kakkar
Publication date
2019/2/5
Journal
Journal of the American Heart Association
Volume
8
Issue
3
Pages
e010510
Description
Background
Using data from the GARFIELD‐AF (Global Anticoagulant Registry in the FIELD–Atrial Fibrillation), we evaluated the impact of chronic kidney disease (CKD) stage on clinical outcomes in patients with newly diagnosed atrial fibrillation (AF).
Methods and Results
GARFIELD‐AF is a prospective registry of patients from 35 countries, including patients from Asia (China, India, Japan, Singapore, South Korea, and Thailand). Consecutive patients enrolled (2013–2016) were classified with no, mild, or moderate‐to‐severe CKD, based on the National Kidney Foundation's Kidney Disease Outcomes Quality Initiative guidelines. Data on CKD status and outcomes were available for 33 024 of 34 854 patients (including 9491 patients from Asia); 10.9% (n=3613) had moderate‐to‐severe CKD, 16.9% (n=5595) mild CKD, and 72.1% (n=23 816) no CKD. The use of oral anticoagulants was influenced by stroke risk …
Scholar articles
S Goto, P Angchaisuksiri, JP Bassand, AJ Camm… - Journal of the American Heart Association, 2019